NASDAQ: ETON - Eton Pharmaceuticals, Inc.

半年間の収益性: +297.87%
セクタ: Healthcare

プロモーションスケジュール Eton Pharmaceuticals, Inc.


会社について

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning.

さらに詳しく
It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

IPO date 2018-11-13
ISIN US29772L1089
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.etonpharma.com
Цена ао 3.81
1日あたりの価格変動: -3.83% (13.57)
週ごとの価格変動: +3.82% (12.57)
月ごとの料金変更: +2.43% (12.74)
3ヶ月間の価格変動: +125% (5.8)
半年間の価格変動: +297.87% (3.28)
年間の価格変動: +197.95% (4.38)
3年間の価格推移: +216.75% (4.12)
5年間の価格推移: +108.13% (6.27)
10年間の価格推移: 0% (13.05)
年初からの価格変動: +4.74% (12.46)

過小評価

名前 意味 学年
P/S 3.78 4
P/BV 7.72 1
P/E 0 0
EV/EBITDA -355.93 0
合計: 3.63

効率

名前 意味 学年
ROA, % -2.95 0
ROE, % -6.05 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -18.75 10
合計: 6

成長の衝動

名前 意味 学年
収益性 Revenue, % 3199.48 10
収益性 Ebitda, % -98.4 0
収益性 EPS, % -96.42 0
合計: 2

ETF 共有, % 年間の利益率, % 配当金, %
iShares Micro-Cap ETF 0.027 17.09 1.54048



スーパーバイザー 役職 支払い 生年
Mr. Sean E. Brynjelsen President, CEO & Director 939.42k 1972 (53 年)
Mr. James R. Gruber CPA CFO, Treasurer & Secretary 554.44k 1972 (53 年)
Mr. David C. Krempa Chief Business Officer 547.86k 1989 (36 年)
Mr. Kevin Guthrie Executive VP of Commercial Operations N/A
Danka Radosavljevic Senior Vice President of Quality & Operations
Mr. Scott Grossenbach Vice President of Sales Operations

住所: United States, Deer Park. IL -, 21925 W. Field Parkway - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.etonpharma.com